Background: Myocardial perfusion imaging shows various patterns in patients with non-ischemic dilated cardiomyopathy (DCM). However, influences of regional abnormalities of myocardial perfusion or ventricular wall motion on prognosis in DCM patients remains to be clarified. Accordingly, we investigated a relation between myocardial perfusion patterns and long-term prognosis in DCM patients. Methods and results: Sixty-two patients were divided into 2 groups according to patterns of 99m Tc-Tetrofosmin scintigraphy, i.e. large focal defects (focal) and minimally impaired perfusion or multiple small defects (non-focal). There were no differences between the 2 groups in left ventricular (LV) end-diastolic dimensions (63.4 ± 9.1 and 63.8.4 ± 7.5 mm, respectively) and LV ejection fraction (30.3 ± 9.2 and 27.9 ± 7.8%, respectively), indicating LV systolic dysfunction was comparable between the groups. The focal group had a higher prevalence of brain natriuretic peptide 200 ng/dl and plasma norepinephrine 500 pg/ml than the non-focal group (p < 0.05), and had longer QRS durations (p < 0.05). The focal group had non-sustained ventricular tachycardia (VT) (p < 0.05) on 24-h electrocardiogram recording and a history of VT/ventricular fibrillation more frequently (p < 0.05), and had higher New York Heart Association functional class than the non-focal group (p < 0.05). The mortality was significantly higher in the focal group (56.0%) than in the non-focal group (28.6%) and the survival curves revealed worse prognosis in the focal group during a follow-up period of 5.3 ± 2.8 years. * Corresponding author. Conclusions: Non-ischemic DCM patients with focal defects are accompanied by more advanced heart failure and poor prognosis compared to those with minimally impaired perfusion or multiple small defects, despite comparable LV systolic dysfunction.
Introduction
Non-ischemic dilated cardiomyopathy (DCM) is presumed to affect the myocardium diffusely in association with global eccentric left ventricular (LV) hypertrophy and reduced LV ejection fraction (EF). Despite this, regional heterogeneity of LV function, metabolism, and perfusion have been demonstrated using echocardiography, left ventriculography, cine magnetic resonance imaging (MRI) and radionuclide studies [1] [2] [3] [4] . Patients with DCM also show various patterns of myocardial perfusion imaging [5, 6] . The severity of myocardial perfusion abnormality may be related with myocardial fibrosis [7] , while the perfusion defect could be improved by ␤-blocker therapy [8] , suggesting the myocardium in the low perfusion area is viable. A previous study [9] showed that patients with a large 201-thallium ( 201 Tl) perfusion defect had worse prognosis in association with more advanced LV dysfunction, as compared to those with minimally impaired perfusion or multiple small defects, while influences of wall motion abnormality on prognosis were inconsistent in relatively short-term follow-up studies, i.e. a study [10] reported worse prognosis in DCM patients with segmental wall motion abnormality than in those with diffuse wall motion abnormality, but the opposite in another study [11] . Therefore, the purpose of the present study was to compare clinical characteristics and long-term prognosis of non-ischemic DCM patients with large, localized myocardial perfusion defect to those with minimally impaired perfusion or multiple small perfusion defects.
Methods

Study patients
We performed a retrospective analysis using clinical records in non-ischemic DCM patients who underwent myocardial perfusion imaging between June 1996 and May 2006. A blanket agreement of usage of clinical data in observational studies is obtained from patients. Sixty-two consecutive patients (43 men and 19 women, mean age 57 ± 14 years) who met the following criteria constituted the study group: LV systolic dysfunction (LVEF < 45%), LV end-diastolic dimension >50 mm on echocardiography and no lumen diameter stenosis 50% in any of the major epicardial coronary arteries and their branches on coronary angiography. No patients had a history of myocardial infarction or chest pain suggestive of myocardial ischemia. Patients were excluded if they had congenital heart disease, valvular heart disease, or general systemic disease, but patients with the dilated stage of hypertrophic cardiomyopathy (HCM) were included.
99m Tc-labeled myocardial scintigraphy 99m Tc-labeled myocardial perfusion imaging was performed within 2 months before or after coronary angiography. Planar and single photon emission computed tomography (SPECT) images were acquired 30 min after intravenous injection of 740 MBq of 99m Tc-labeled tetrofosmin at rest using a 3-headed gamma camera (Toshiba GCA-9300A/DI, Tokyo, Japan) with a high-resolution parallel-hole collimator. After transaxial reconstruction using a filtered back projection algorithm with Butterworth (filter order 8, cutoff frequency 0.3 cycle/pixel) and Ramp filters, short-axis, vertical and horizontal long-axis tomograms were obtained without attenuation corrections.
Images were interpreted by 2 experienced observers who were unaware of the angiographic and echocardiographic results. SPECT images were analyzed on the 17 segments of LV with a 4-point grading scale: 0 = normal uptake; 1 = equivocal reduction of uptake; 2 = moderate reduction of uptake; 3 = severe reduction of uptake; and 4 = no uptake [12] , and summed severity scores were calculated. Patients were divided into 2 groups according to the myocardial perfusion patterns; large defects with the defect size 2 consecutive segments and grade 2 reduction (focal defect pattern) and minimally impaired perfusion (grade 1) or multiple small defects with the size of each defect 1 segment but grade 2 reduction (non-focal defect pattern).
Twenty-four-hour electrocardiograph recording
Within 1 month of myocardial scintigraphy 24-h electrocardiograph (ECG) recording was performed. ECG was analyzed using a Holter analysis system (DMW-900, Fukuda Denshi, Tokyo, Japan). Special attention was given to presence of ventricular tachyarrhythmias. Non-sustained ventricular tachycardia (VT) was defined as triplet or more of premature ventricular contractions, and sustained VT, as VT lasting 30 s or more. A history of sustained VT or ventricular fibrillation (VF) was assessed using a clinical record.
Statistics
The results are expressed as mean ± SD. Variables between the groups were compared using unpaired Student's ttest. For comparisons of categorical variables between the groups, the chi-square test or Fisher's exact test was used as appropriate. Logistic regression models were applied to assess the independent effect of various clinical indices on prognosis. The outcomes were displayed with Kaplan-Meier event-free survival curves and compared with use of the log-rank test. A p-value less than 0.05 was considered statistically significant. Statistical analyses were performed with SPSS (SPSS 11.0J, Chicago, IL, USA) and StatView (StatView Version 4.5, Berkeley, CA, USA). 
Results
Representative examples of myocardial perfusion pattern, i.e. focal and non-focal defect patterns are shown in Fig. 1 . Of 62 DCM patients, 27 patients had focal defects and 35 patients, non-focal defects. In the focal group, perfusion defects were found in various areas of LV, including antero-septal, infero-posterior, and lateral walls, and a considerable number of patients with focal defect had perfusion defects more than one area (Fig. 2) . As shown in Table 1 , there were no differences in the prevalence of hypertension, diabetes mellitus, dilated stage of HCM, or atrial fibrillation between the 2 groups.
There were no differences in echocardiographic indices including LV end-diastolic and end-systolic dimensions and LVEF between the 2 groups, suggesting LV systolic dys- Figure 2 The frequency of myocardial perfusion defects in each area of the focal group. Open bars indicate patients with focal defects in one area, closed bars patients with those in more than one area. function was comparable between the groups. However, summed severity scores of myocardial perfusion were greater in patients with focal defect than in those with non-focal defect (Table 1) . Patients with focal defect had NYHA functional class II, BNP 200 pg/dl, and plasma norepinephrine 500 pg/ml more frequently at the beginning of the study compared with the non-focal group ( Table 1) .
As compared with the non-focal group, the focal group had characteristic ECG findings. That is, QRS duration was significantly longer, non-sustained VT was recorded more frequently on Holter ECG recording, and VT and VF were complicated more frequently in the focal group (Fig. 3) .
During a mean follow-up period of 5.3 ± 2.8 years, 23 patients died and 2 patients were lost to follow-up. Of 13 patients with implantable cardioverter defibrillator (ICD), 6 patients received successful defibrillation shock during the follow-up period, and they were defined as non-survivors at the time of defibrillation shock in the following analysis. There were 10 non-survivors in the non-focal group and 14 non-survivors in the focal groups, and the mortality was higher in the focal group (Table 2) . Logistic regression analysis was performed to determine the independent effect on survival of clinical characteristics including age, sex, NYHA functional class, echocardiographic indices, and QRS duration. Age 65 years, LVEF < 30%, and QRS duration 120 ms emerged as independent predictors of mortality (Table 3) . The scintigraphic pattern of focal defect did not reach statistical significance when it was included in the logistic regression analysis, but the above 3 factors remained to be independent predictors. As shown in Fig. 4 , patients with focal defect had worse survival than those with non-focal defect, despite LV systolic dysfunction being comparable between the 2 groups. 
Figure 4
Kaplan-Meier survival curves of the focal and nonfocal groups.
Discussion
Major findings of the present study were as follows. First, non-ischemic DCM patients with moderate to severe LV dysfunction had various patterns of myocardial perfusion imaging, and more than 40% of these patients had focal perfusion defect. Second, patients with focal defect had more severe heart failure symptoms, more frequent ventricular tachyarrhythmias, and worse prognosis compared to those with minimally impaired perfusion or multiple small defects, despite LV systolic dysfunction being comparable between these groups.
Perfusion imaging in DCM patients
Non-ischemic DCM is typically associated with global eccentric LV hypertrophy, increased LV volume, and reduced LV systolic function. However, heterogeneity in regional LV function has been demonstrated in patients with DCM; the pattern of heterogeneity widely varied among these patients, i.e. reduced function in the inferior, septal, or anterior walls, but preserved function typically in the lateral and basal walls [1] [2] [3] [4] 13] . Similarly, several patterns of myocardial perfusion imaging were reported in patients with DCM [9] . Many possibilities have been proposed as the mechanism or mechanisms responsible for heterogeneous myocardial perfusion in DCM patients [14] [15] [16] [17] . Among them are partial-volume effect due to reduced wall thickening, down-regulated perfusion secondary to reduced oxygen demand, increased intramyocardial pressure during diastole, and fibrotic alterations. The severity of 201 Tl perfusion defect was strongly related with advancement of myocardial fibrosis in patients with DCM [18] . Other investigators [19] , however, found that the ventricular wall was thin and no fibrosis was observed at the site of 201 Tl defect in patients with DCM.
A total of 11 of 62 patients in the present study suffered from dilated stage of HCM. A previous study [20] has shown that patients with HCM often have exercise-induced reversible or fixed defect in myocardial perfusion scintigram even in the absence of associated coronary artery disease. The hypoperfusion may be explained by regional imbalance in myocardial oxygen supply-demand, microvascular disease, or systolic compression of coronary artery in these patients with HCM [21] . In the present study, however, the frequency of patients with dilated stage of HCM did not differ between the focal and non-focal groups. Thus, the precise mechanism of perfusion abnormality observed in our patients with non-ischemic DCM remains unclear.
Wallis et al. [11] showed that DCM patients with segmental LV wall motion abnormality had better prognosis associated with lower LV end-diastolic dimension and greater LVEF compared to those with diffuse wall motion abnormality. Yamaguchi et al. [22] also reported that DCM patients with diffuse LV wall motion abnormality had more elevated LV end-diastolic pressure and a trend to greater LV end-diastolic volume compared to those with segmental wall motion abnormality despite similar LVEF between these 2 groups. They also found a correlation between a reduced 201 Tl uptake and regional wall motion abnormality within the left ventricle [22] . In contrast, other investigators [10] showed that segmental wall motion abnormality was frequently observed in DCM and was associated with more severe systolic dysfunction and worse prognosis. In the present study, LV systolic function as expressed by LVEF and LV end-diastolic and systolic dimensions was similar between the focal and non-focal groups, but patients with focal defect had worse prognosis in association with more severe symptoms and higher levels of neurohumoral factors compared to the non-focal group. Regional LV wall motion, which might have affected the worse clinical outcome in the focal defect group, was not evaluated in the present study. A considerable number of DCM patients had late gadolinium enhancement with cardiovascular magnetic resonance (CMR), especially in midwall enhancement which was similar to the fibrosis found at autopsy [23] . The late enhancement with CMR predicted adverse cardiac outcome, and also predicted interventricular systolic dyssynchrony in patients with DCM [24] [25] [26] . We did not perform a CMR study, but patients with focal defect might have more severe fibrosis and ventricular dyssynchrony than those with non-focal defect.
In patients with heart failure, QRS duration correlates inversely with LV contractile function as indexed by the maximal rate of pressure rise [27, 28] . Previous studies [29, 30] showed that QRS duration might be a marker of high risk in patients with DCM. In the present study, QRS duration was longer in the focal group than in the non-focal group and multivariate analysis actually indicated QRS duration 120 ms was an independent risk factor for the non-survivors. Fibrosis in the area of focal perfusion defect might be associated with intraventricular conduction delay, thereby leading to intraventricular dyssynchrony. A failing heart accompanied by LV dyssynchrony might have severely impaired LV diastolic function due to prolonged systolic intervals and dyssynchronous relaxation and also reduced energy efficiency or metabolic alterations compared to a failing heart without LV dyssynchrony [31, 32] . Therefore, a failing heart with focal perfusion defect and LV dyssynchrony may result in worse hemodynamic conditions as compared to that without focal perfusion defect or dyssynchrony, even if both hearts have similar LVEF and LV dimensions. LV with focal perfusion defect due to myocardial fibrosis might be associated with arrhythmia substrate and, might be at risk for ventricular arrhythmias [33] .
Limitations
The present study was limited for several reasons. First, we did not determine regional LV wall motion abnormality, but just determined LV end-diastolic and end-systolic dimensions and EF. Therefore, it was obscure whether patients with focal perfusion defect actually had heterogeneous LV contraction, i.e. LV dyssynchrony or not. However, previous studies [1] [2] [3] [4] [5] have clearly shown in patients with DCM that heterogeneity of LV contraction exists commonly and focal perfusion defect is associated with regional wall motion abnormalities. Second, the present study was retrospectively performed and patients were divided into 2 groups according to visual assessment of SPECT images but not to quantitative assessment. The influences of myocardial perfusion images assessed by quantitative analysis on prognosis in patients with DCM should be prospectively studied, although the use of renin-angiotensin system inhibitors or ␤-blockers has improved the prognosis of DCM patients [34] .
In summary, patients with DCM had various patterns in myocardial perfusion images and were frequently associated with focal perfusion defect despite no significant coronary artery stenosis. Focal perfusion defects may be a marker of worse prognosis in patients with non-ischemic DCM.
